비뇨의학 Urology Digest ISSN:2713-7910(Print) 2733-5453(Online)

Baillargeon J et al., The association of body mass index and prostate-specific antigen in a population-based study, Cancer, 2005

Hamilton RJ et al., The influence of statin medications on prostate-specific antigen levels, J Natl Cancer Inst, 2008

FDA Approved Drug Products: PROSCAR (finasteride) tablets (website: http://extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020180s047lbl.pdf)

Smith AB et al., Finasteride in the treatment of patients with benign prostatic hyperplasia: a review, Ther Clin Risk Manag, 2009

Finasteride - StatPearls - NCBI Bookshelf (website: https://www.ncbi.nlm.nih.gov/books/NBK513329/)

Kaplan SA et al., PSA response to finasteride challenge in men with a serum PSA greater than 4 ng/ml and previous negative prostate biopsy: Preliminary study, Urology, 2002

Andriole GL et al., Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride, J Urol, 2006

Marks LS et al., The interpretation of serum prostate specific antigen in men receiving 5a-reductase inhibitors: A review and clinical recommendations, J Urol, 2006

Kulkarni GS et al., Evidence for a biopsy derived grade artifact among larger prostate glands, J Urol, 2006

McClellan KJ et al., Finasteride: a review of its use in male pattern hair loss, Drugs, 1999